Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan, China.
Acta Pharmacol Sin. 2010 Aug;31(8):889-99. doi: 10.1038/aps.2010.66. Epub 2010 Jul 19.
Ferulic acid (4-hydroxy-3-methoxycinnamic acid, FA) provides neuroprotection against apoptosis in a transient middle cerebral artery occlusion (MCAo) model. This study was to further investigate the anti-apoptotic effect of FA during reperfusion after cerebral ischemia.
Rats were subjected to 90 min of cerebral ischemia followed by 3 or 24 h of reperfusion after which they were sacrificed.
Intravenous FA (100 mg/kg) administered immediately after middle cerebral artery occlusion (MCAo) or 2 h after reperfusion effectively abrogated the elevation of postsynaptic density-95 (PSD-95), neuronal nitric oxide synthase (nNOS), inducible nitric oxide synthase (iNOS), nitrotyrosine, and cleaved caspase-3 levels as well as apoptosis in the ischemic cortex at 24 h of reperfusion. FA further inhibited Bax translocation, cytochrome c release, and p38 mitogen-activated protein (MAP) kinase phosphorylation. Moreover, FA enhanced the expression of gamma-aminobutyric acid type B receptor subunit 1 (GABA(B1)) in the ischemic cortex at 3 and 24 h of reperfusion. In addition, nitrotyrosine-positive cells colocalized with cleaved caspase-3-positive cells, and phospho-p38 MAP kinase-positive cells colocalized with nitrotyrosine- and Bax-positive cells, indicating a positive relationship among the expression of nitrotyrosine, phospho-p38 MAP kinase, Bax, and cleaved caspase-3. The mutually exclusive expression of GABA(B1) and nitrotyrosine revealed that there is a negative correlation between GABA(B1) and nitrotyrosine expression profiles. Additionally, pretreatment with saclofen, a GABA(B) receptor antagonist, abolished the neuroprotection of FA against nitric oxide (NO)-induced apoptosis.
FA significantly enhances GABA(B1) receptor expression at early reperfusion and thereby provides neuroprotection against p38 MAP kinase-mediated NO-induced apoptosis at 24 h of reperfusion.
阿魏酸(4-羟基-3-甲氧基肉桂酸,FA)在短暂性大脑中动脉闭塞(MCAo)模型中提供神经保护作用,防止细胞凋亡。本研究旨在进一步探讨缺血后再灌注期间 FA 的抗细胞凋亡作用。
大鼠接受 90 分钟大脑中动脉闭塞(MCAo),然后再灌注 3 或 24 小时后处死。
MCAo 后立即给予静脉内 FA(100mg/kg)或再灌注后 2 小时给予 FA,可有效阻断再灌注 24 小时时缺血皮质中突触后密度-95(PSD-95)、神经元型一氧化氮合酶(nNOS)、诱导型一氧化氮合酶(iNOS)、硝基酪氨酸和裂解 caspase-3 水平以及细胞凋亡的升高。FA 进一步抑制 Bax 易位、细胞色素 c 释放和 p38 丝裂原激活蛋白(MAP)激酶磷酸化。此外,FA 增强了缺血皮质中γ-氨基丁酸 B 型受体亚基 1(GABA(B1))在再灌注 3 和 24 小时时的表达。此外,硝基酪氨酸阳性细胞与裂解 caspase-3 阳性细胞共定位,磷酸化 p38 MAP 激酶阳性细胞与硝基酪氨酸和 Bax 阳性细胞共定位,表明硝基酪氨酸、磷酸化 p38 MAP 激酶、Bax 和裂解 caspase-3 的表达之间存在正相关关系。GABA(B1)和硝基酪氨酸的相互排斥表达表明 GABA(B1)和硝基酪氨酸表达谱之间存在负相关关系。此外,GABA(B)受体拮抗剂 saclofen 的预处理消除了 FA 对一氧化氮(NO)诱导的细胞凋亡的神经保护作用。
FA 在再灌注早期显著增强 GABA(B1)受体表达,从而在再灌注 24 小时时提供对 p38 MAP 激酶介导的 NO 诱导的细胞凋亡的神经保护作用。